Subtype
Liver Carcinoma
CI-CAN-00001073Explore in graph →
783 active trials14 approved drugs17 evidence items
- NCIt
- C7927
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001073Explore in graph →
Clinical trials
3,367 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (386)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01129570 | Siliphos in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 3 | Abby SiegelOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01098760 | Hepatocellular Carcinoma - Advanced Stage - Sorafenib Trial in Taiwanese Patients(HATT) | completed | Phase 4 | 151 | BayerINDUSTRY | 1 | Oct 31, 2013 | clinicaltrials |
| NCT01320852 |
| PET Scan as a Screening Tool for Liver Transplant in Patients With Hepatocellular Carcinoma (HCC) |
| completed |
| N/A |
| 100 |
| McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER |
| 1 |
| Oct 25, 2013 |
| clinicaltrials |
| NCT01518829 | Procalcitonin in Hepatocellular Carcinoma | completed | — | 42 | Ain Shams UniversityOTHER | 1 | Oct 1, 2013 | clinicaltrials |
| NCT01520779 | Recurrence of Hepatocellular Carcinoma | completed | — | 99 | Ain Shams UniversityOTHER | 1 | Oct 1, 2013 | clinicaltrials |
| NCT00956436 | Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 40 | BiogenINDUSTRY | 4 | Sep 16, 2013 | clinicaltrials |
| NCT01204177 | Assessing BAY86-9766 Plus Sorafenib for the Treatment of Liver Cancer.(BASIL) | completed | Phase 2 | 70 | BayerINDUSTRY | 4 | Sep 6, 2013 | clinicaltrials |
| NCT01934829 | Urea Cream Treatment Sorafenib-Associated HSFR in HCC | completed | Phase 2 | 871 | Chinese Anti-Cancer AssociationOTHER | 1 | Sep 4, 2013 | clinicaltrials |
| NCT00820157 | Cytoreductive Surgery and Transarterial Chemoembolization (TACE) Versus TACE for Hepatocellular Carcinoma(TACE) | completed | N/A | 120 | Eastern Hepatobiliary Surgery HospitalOTHER | 1 | Aug 13, 2013 | clinicaltrials |
| NCT01904942 | Study of Hepatocellular Carcinoma in Cirrhotic Patients(CIRCE ProSpec) | completed | — | 600 | Centre Hospitalier Universitaire DijonOTHER | 0 | Jul 22, 2013 | clinicaltrials |
| NCT00328770 | De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma | completed | Phase 2 / Phase 3 | 70 | University of AlbertaOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00052364 | Oxaliplatin in Treating Patients With Liver Cancer | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00238394 | Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00033462 | Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer | completed | Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00077441 | Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00242502 | Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery | completed | Phase 2 | 62 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT00769535 | Relationship Between Polymorphism of Heat Shock Protein 70 Gene and Hepatocellular Carcinoma(HSP70) | completed | N/A | 600 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00629486 | Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma | completed | N/A | 300 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Apr 18, 2013 | clinicaltrials |
| NCT00764140 | Tumor Growth Factors in Hepatocellular Carcinoma | completed | — | 400 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Apr 18, 2013 | clinicaltrials |
| NCT00988741 | Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy | completed | Phase 2 | 107 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 5 | Feb 28, 2013 | clinicaltrials |
| NCT00071994 | Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 59 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01042041 | Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer | completed | Phase 1 | 18 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01394497 | Use of N-Acetylcysteine During Liver Procurement | completed | Phase 2 | 140 | Azienda Ospedaliera di PadovaOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT01102400 | A Study of MEDI-575 in Patients With Advanced Solid Malignancies | completed | Phase 1 | 22 | AstraZenecaINDUSTRY | 1 | Feb 6, 2013 | clinicaltrials |
| NCT00028496 | Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | 48 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00047346 | Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00030498 | Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00844623 | TK-based Suicide Gene Therapy for Hepatocellular Carcinoma | completed | Phase 1 | 10 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT01040559 | Chemoembolisation of Non Resectable, Non Metastatic Hepatocellular Carcinomas | completed | Phase 1 | 18 | Centre Hospitalier Universitaire DijonOTHER | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00517920 | Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 44 | AbbVie (prior sponsor, Abbott)INDUSTRY | 4 | Jan 4, 2013 | clinicaltrials |
| NCT00936689 | Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE(PRECISION-IT) | completed | Phase 4 | 178 | Rita GolfieriOTHER | 1 | Dec 24, 2012 | clinicaltrials |
| NCT00493402 | Different Regimens of Transarterial Chemoembolization for Hepatocellular Carcinoma(TACEforHCC) | completed | Phase 3 | 365 | Sun Yat-sen UniversityOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00725335 | Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy | completed | N/A | 498 | Southwest Hospital, ChinaOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT00712855 | A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma(HCC) | completed | Phase 1 | 23 | Human Genome Sciences Inc., a GSK CompanyINDUSTRY | 1 | Oct 30, 2012 | clinicaltrials |
| NCT01717729 | Hepatocellular Carcinoma Treated With Iodine-125 Implantation | completed | Phase 3 | 136 | The Second People's Hospital of GuangDong ProvinceOTHER | 0 | Oct 30, 2012 | clinicaltrials |
| NCT01657695 | Hepatocellular Carcinoma Growth and Molecular Aggressiveness(UniRer) | completed | — | 78 | Prof. Facchinetti FabioOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT00614913 | Proton Beam Therapy for Treatment of Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 76 | Loma Linda UniversityOTHER | 1 | Aug 20, 2012 | clinicaltrials |
| NCT00080236 | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | completed | Phase 2 | 99 | Conatus Pharmaceuticals Inc.INDUSTRY | 2 | Aug 10, 2012 | clinicaltrials |
| NCT00802555 | Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) | completed | Phase 1 | 21 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 3 | Jul 12, 2012 | clinicaltrials |
| NCT00999882 | Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients | completed | Phase 1 | 26 | AstraZenecaINDUSTRY | 2 | Jul 10, 2012 | clinicaltrials |
| NCT00731445 | Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 43 | Zeria PharmaceuticalINDUSTRY | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01008358 | Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 20 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00646100 | Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis(TACEHCC) | completed | Phase 4 | 164 | Sun Yat-sen UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00919009 | Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Cancer Center, KoreaOTHER_GOV | 1 | May 30, 2012 | clinicaltrials |
| NCT00867750 | SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma(SIRTACE) | completed | Phase 2 | 28 | Sirtex MedicalINDUSTRY | 2 | May 7, 2012 | clinicaltrials |
| NCT00775073 | Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 | completed | Phase 2 | 33 | Gerhard TreiberINDIV | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00662246 | Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma | completed | Phase 1 | 24 | National Cancer Center, KoreaOTHER_GOV | 1 | Apr 3, 2012 | clinicaltrials |
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 35 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00988195 | Study of Pegylated Human Recombinant Arginase for Liver Cancer | completed | Phase 1 | 15 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Nov 25, 2013source: clinicaltrials